Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2
Open accessAbstract
The differential modulation of learning and anxiety by corticotropin-releasing factor (CRF) through CRF receptor subtypes 1 (CRFR1) and 2 (CRFR2) is demonstrated. As learning paradigm, context- and tone-dependent fear conditioning of the mouse was used. Injection of CRF into the dorsal hippocampus before training enhanced learning through CRFR1 as demonstrated by the finding that this effect was prevented by the local injection of the unselective CRFR antagonist astressin, but not by the CRFR2-specific antagonist antisauvagine-30 (anti-Svg-30). In contrast, injection of CRF into the lateral intermediate septum impaired learning through CRFR2, as demonstrated by the ability of antisauvagine-30 to block this effect. When antisauvagine-30 was injected alone into the lateral intermediate septum, learning was enhanced. Such tonic control of learning was not observed when astressin or antisauvagine-30 was injected into the dorsal hippocampus. Injection of CRF after the training into the dorsal hippocampus and the lateral intermediate septum also enhanced and impaired learning, respectively. Thus, it was indicated that CRF acted on memory consolidation. It was concluded that the observed effects reflected changes of associative learning and not arousal, attention, or motivation. Although a dose of 20 pmol human/rat CRF was sufficient to affect learning significantly, a fivefold higher dose was required to induce anxiety by injection into the septum. Immobilization for 1 hr generated a stress response that included the induction of anxiety through septal CRFR2 and the subsequent enhancement of learning through hippocampal CRFR1. The involvement of either receptor subtype was demonstrated by region-specific injections of astressin and antisauvagine-30.
AI snapshot
Written from the paper’s full text.
TL;DR
In male BALB/c mice, hippocampal CRF receptor 1 (CRFR1) enhanced fear conditioning, whereas septal CRFR2 impaired it and mediated CRF-induced anxiety. Immobilization stress reproduced these effects sequentially: septal CRFR2-mediated anxiety at 30 min and hippocampal CRFR1-mediated enhancement of fear learning at 3 hr.
Key findings
- Intrahippocampal h/rCRF enhanced context- and tone-dependent fear conditioning; this was blocked by the nonselective CRFR antagonist astressin but not by the CRFR2-selective antagonist antisauvagine-30 (anti-Svg-30), implicating CRFR1. Intra-septal h/rCRF impaired conditioning; this was blocked by both astressin and anti-Svg-30, implicating CRFR2.
- Antagonists alone injected into the lateral intermediate septum enhanced fear conditioning to context and tone, suggesting tonic impairment of learning through septal CRFR2; hippocampal antagonist injections alone had no effect.
- A dose of 20 pmol h/rCRF was sufficient to affect learning, whereas a fivefold higher dose was required to induce anxiety after septal injection. Septal h/rCRF at 500 ng per mouse reduced open-arm time and entries in the elevated plus-maze, and this was antagonized by astressin and anti-Svg-30.
- One-hour immobilization stress increased anxiety at 30 min via septal CRFR2 and enhanced fear conditioning at 3 hr via hippocampal CRFR1; astressin injected into the hippocampus prevented the stress-induced enhancement of conditioned fear, and septal astressin or anti-Svg-30 prevented stress-induced anxiety.
Methods
- Nine-week-old male BALB/c mice were implanted with bilateral cannulae into the lateral ventricles, dorsal hippocampus, or lateral intermediate septum; cannula placement was verified histologically, and only correctly placed mice were analyzed (7–13 mice per group).
- Context- and tone-dependent fear conditioning used a 3 min context, 30 sec 10 kHz tone, and 2 sec 0.7 mA footshock; freezing was scored 24 hr later as the fear index. Anxiety was assessed with the elevated plus-maze, and stress was 1 hr immobilization.
- Peptides included h/rCRF, rat urocortin, ovine CRF, h/rCRF(6–33), astressin, and anti-Svg-30; effects were analyzed with ANOVA followed by Bonferroni-Dunn tests.
Limitations
- The paper states that it is not clear whether the anxiety response is necessary for the subsequent enhancement of learning or whether these responses occur independently. It also notes that in vivo interactions of h/rCRF and urocortin with their receptors differed from in vitro findings, possibly due to partial agonism of rat urocortin toward CRFR1.
- Evident from the text: the study used only male BALB/c mice and a single immobilization stressor, so generality across sex, strain, and stress type is not established. CRFR1 mediation was inferred from blockade by nonselective astressin and lack of blockade by CRFR2-selective anti-Svg-30, rather than by a CRFR1-selective antagonist.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 40 cited sources checked · 0 supported · 0 flagged
- Findingown data§ Modulation of Learning and Anxiety by Corticotropin-Releasing Factor (CRF) and Stress: Differential Roles of CRF Receptors 1 and 2
Injection of CRF into the dorsal hippocampus before training enhanced learning through CRFR1, as shown by blockade with astressin but not antisauvagine-30.
“Injection of CRF into the dorsal hippocampus before training enhanced learning through CRFR1 as demonstrated by the finding that this effect was prevented by the local injection of the unselective CRFR antagonist astressin, but not by the CRFR2-specific antagonist antisauvagine-30 (anti-Svg-30).”
- Also stated in: § Modulation of fear conditioning by h/rCRF is restricted to a small time window · plain
“The enhancement of fear conditioning after i.h.injection of h/rCRF was completely blocked by previous administration of astressin but not antisauvagine-30 (anti-Svg-30) (Fig. 6a)”
- Also stated in: § CRF enhances fear conditioning through CRFR1 and impairs it through CRFR2 · plain
“Because the enhancement of fear conditioning by i.h.injection of h /rCRF was prevented by astressin but not anti-Svg-30, it was concluded that this effect was mediated by CRFR1.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
- Also stated in: § Modulation of fear conditioning by h/rCRF is restricted to a small time window · plain
- Findingown data§ Modulation of Learning and Anxiety by Corticotropin-Releasing Factor (CRF) and Stress: Differential Roles of CRF Receptors 1 and 2
Injection of astressin or antisauvagine-30 alone into the dorsal hippocampus did not affect learning.
“Such tonic control of learning was not observed when astressin or antisauvagine-30 was injected into the dorsal hippocampus.”
- Also stated in: § Modulation of fear conditioning by h/rCRF is restricted to a small time window · plain
“Administration of the CRF receptor antagonists astressin and anti-Svg-30 alone into the hippocampus did not affect fear conditioning”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
- Also stated in: § Modulation of fear conditioning by h/rCRF is restricted to a small time window · plain
- Findingown data§ Modulation of Learning and Anxiety by Corticotropin-Releasing Factor (CRF) and Stress: Differential Roles of CRF Receptors 1 and 2
Injection of CRF into the lateral intermediate septum impaired learning through CRFR2, as shown by blockade with antisauvagine-30.
“In contrast, injection of CRF into the lateral intermediate septum impaired learning through CRFR2, as demonstrated by the ability of antisauvagine-30 to block this effect.”
- Also stated in: § Modulation of fear conditioning by h/rCRF is restricted to a small time window · plain
“Both astressin and anti-Svg-30 blocked the memory-impairing effects of i.s.injection of h/rCRF (Fig. 6b).”
- Also stated in: § CRF enhances fear conditioning through CRFR1 and impairs it through CRFR2 · hedged
“In contrast, the impairment of fear conditioning observed after i.s.application of h /rCRF was mediated by CRFR2, as indicated by the ability of both astressin and anti-Svg-30 to block this effect.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
- Also stated in: § Modulation of fear conditioning by h/rCRF is restricted to a small time window · plain
- Findingown data§ Modulation of Learning and Anxiety by Corticotropin-Releasing Factor (CRF) and Stress: Differential Roles of CRF Receptors 1 and 2
Injection of antisauvagine-30 alone into the lateral intermediate septum enhanced learning.
“When antisauvagine-30 was injected alone into the lateral intermediate septum, learning was enhanced.”
- Also stated in: § Modulation of fear conditioning by h/rCRF is restricted to a small time window · plain
“Administration of the CRF receptor antagonists astressin and anti-Svg-30 alone into the hippocampus did not affect fear conditioning, whereas their i.s.injection significantly enhanced fear conditioning to context (F (5,42) ϭ 12.089, p Ͻ 0.001) and tone (F (5,42) ϭ 11.664, p Ͻ 0.001).”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
- Also stated in: § Modulation of fear conditioning by h/rCRF is restricted to a small time window · plain
- Findingown data
The strongest enhancement of fear conditioning after intracerebroventricular injection was observed with h/rCRF.
“The strongest effect was observed after intracerebroventricular injection of h/rCRF.”
Quote in the paperNot a substantial claim
- Findingown data
Intracerebroventricular injection of h/rCRF, h/rCRF(6-33), rUcn, and oCRF dose-dependently enhanced fear conditioning to both context and tone.
“Statistical analysis (twoway ANOVA followed by the Bonferonni-Dunn test) revealed that h/r CRF, h/r CRF (6 -33), rUcn, and oCRF dosedependently enhanced fear conditioning to both context, F (12,103) ϭ 5.158, p Ͻ 0.001 (Fig. 1a) and tone, F (12,103) ϭ 5.365, p Ͻ 0.001 (Fig. 2b).”
Quote in the paperSubstantial claim - Findingown data
Injection of CRF-like peptides into the parietal somatosensory cortex and striatum did not produce significant effects on context- and tone-dependent fear conditioning.
“Injection of CRF-like peptides into the parietal somatosensory cortex and striatum, brain regions adjacent to the hippocampus and septum, respectively, did not produce any significant effects on contextand tone-dependent fear conditioning (Fig. 3c,d).”
Quote in the paperSubstantial claim - Findingown data
oCRF and h/rCRF(6-33) did not affect fear conditioning after i.s. injection.
“whereas oCRF and h /r CRF(6 -33) did not affect fear conditioning after i.s.injection.”
Quote in the paperSubstantial claim - Findingown data
The lowest doses of CRF-like peptides that significantly enhanced fear conditioning were 100 ng (20 pmol) h/rCRF, 200 ng (40 pmol) rUcn, 200 ng (40 pmol) oCRF, and 200 ng (60 pmol) h/rCRF(6-33).
“The lowest doses of CRF-like peptides per mouse that produced significant enhancement of conditioning to context and tone were 100 ng (20 pmol) h/rCRF, 200 ng (40 pmol) rUcn, 200 ng (40 pmol) oCRF, and 200 ng(60 pmol) h/rCRF (6 -33).”
Quote in the paperSubstantial claim - Findingown data
h/rCRF was more effective than Ucn in modulating fear conditioning after i.s. injection.
“h /rCRF was more effective than Ucn in modulating fear conditioning, whereas oCRF and h /r CRF(6 -33) did not affect fear conditioning after i.s.injection.”
Quote in the paperSubstantial claim - Findingown data
After intrahippocampal injection, all CRF-like peptides enhanced acquisition of context-dependent and tone-dependent fear.
“Similarly, all CRF-like peptides enhanced acquisition of context-dependent (F (4,32) ϭ 10.795, p Ͻ 0.001) and tone-dependent fear (F (4,32) ϭ 9.881, p Ͻ 0.001) (Fig. 3a), after intrahippocampal (i.h.) injection.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
- Findingown data
Injection of h/rCRF or Ucn into the lateral intermediate septum significantly impaired context-dependent and tone-dependent fear conditioning.
“In contrast, injection of h /rCRF or Ucn into the lateral intermediate septum (i.s.) significantly impaired context-dependent (F (4,32) ϭ 15.388, p Ͻ 0.001) and tone-dependent fear conditioning (F (4,32) ϭ 14.256, p Ͻ 0.001) (Fig. 3b).”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
- Findingown data
One hour immobilization produced anxious behavior when applied 30 min before the elevated plus-maze test, as revealed by reduced time spent and number of entries on the open arms.
“One hour immobilization produced anxious behavior when applied 30 min before the elevated plus-maze test (Fig. 9a,b), as revealed by reduced time spent and number of entries on the open arms of the maze (F (3,37) ϭ 6.323, p Ͻ 0.01).”
Quote in the paperSubstantial claim - Findingown data
In mice subjected to 1 hr immobilization stress, fear conditioning to context and tone was significantly increased 3 hr after termination of the stress compared with nonstressed controls.
“In mice subjected to 1 hr immobilization stress, fear conditioning to context ((F 3,40 ϭ 7.134, p Ͻ 0.01) and tone (F 3,40 ϭ 6.795, p Ͻ 0.01) was significantly increased 3 hr after termination of the stress when compared with nonstressed controls (Fig. 8a).”
Quote in the paperSubstantial claim - Findingown data
The dose required to produce a maximal effect after i.h. injection was 50 ng h/rCRF per injection site.
“The dose required to produce a maximal effect after i.h.injection (to 100% of values observed in mice injected with aCSF alone, in the absence of peptide) was 50 ng h/rCRF per injection site (Fig. 4a,b).”
Quote in the paperSubstantial claim - Findingown data
Both astressin and anti-Svg-30 blocked the memory-impairing effects of i.s. injection of h/rCRF.
“Both astressin and anti-Svg-30 blocked the memory-impairing effects of i.s.injection of h/rCRF (Fig. 6b).”
Quote in the paperSubstantial claim - Findingown data
Context-dependent fear was impaired by i.s. injection of h/rCRF before and immediately after training, but not 1 hr after training.
“Context-dependent fear was impaired by i.s.injection of h/rCRF before and immediately after the training, whereas injection 1 hr after the training was ineffective.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
- Findingown data
Astressin completely antagonized stress-induced enhancement of conditioned fear when given by i.h. injection either before the immobilization stress or before the training.
“Astressin completely antagonized stress-induced enhancement of conditioned fear when given by i.h.injection either before the immobilization stress or before the training (Fig. 8b).”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
- Findingown data
i.h. administration of h/rCRF immediately after training enhanced acquisition of context-dependent and tone-dependent fear.
“In addition to the effects observed previously when h/rCRF was injected before the training, i.h.administration of h/rCRF immediately after the training also enhanced acquisition of context-dependent (F (5,48) ϭ 9.568, p Ͻ 0.001) and tonedependent fear (F (5,48) ϭ 9.344, p Ͻ 0.001) (Fig. 5a).”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
- Findingown data
i.h. injection of h/rCRF 1 hr after training did not exhibit any significant effect.
“An h/rCRF i.h.injection 1 hr after training did not exhibit any significant effect.”
Quote in the paperSubstantial claim - Findingown data
i.s. injection of h/rCRF differentially affected acquisition of context-dependent and tone-dependent fear conditioning.
“An i.s.injection of h/rCRF differentially affected acquisition of context-dependent (F (5,46) ϭ 9.133, p Ͻ 0.001) and tonedependent fear conditioning (F (5,46) ϭ 7.95, p Ͻ 0.001) (Fig. 5b).”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
- Findingown data
Tone-dependent fear was impaired only when i.s. injection of h/rCRF was given before training.
“Tone-dependent fear was impaired only when i.s.injection of h/rCRF was given before the training.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
- Findingown data
The dose of h/rCRF that modulated fear conditioning did not affect plus-maze behavior.
“The dose of h /rCRF modulating fear conditioning did not affect plus-maze behavior (Fig. 7), as evaluated by time spent, number of entries, and distance crossed on the open and closed arms of an elevated plus-maze.”
Quote in the paperSubstantial claim - Findingown data
The same dose (50 ng) applied intracerebroventricularly produced an enhancement of 55% of control values.
“The same dose applied intracerebroventricularly produced an enhancement of 55% of control values (Fig. 2a,b).”
Quote in the paperSubstantial claim - Findingreasoning
CRFR antagonists astressin and anti-Svg-30 produce an opposite effect compared with h/rCRF.
“This finding was consistent with the tonic role of septal CRFR2, as demonstrated by the ability of the CRFR antagonists astressin and anti-Svg-30 to produce an opposite effect when compared with h/rCRF.”
Quote in the paperSubstantial claim - Findingreasoning
After post-training i.s. injections of h/rCRF, a dissociation of CRFR2-mediated effects on context and tone was observed.
“After post-training i.s.injections of h/rCRF, a dissociation of CRFR2-mediated effects on context and tone was observed.”
Quote in the paperSubstantial claim - Findingown data
h/rCRF modulates the acquisition of the fear response when injected immediately after training but not at a later time point.
“Modulation of conditioned fear observed in the present experiments was specific for learning and not performance, as demonstrated by the efficiency of h/rCRF to modulate the acquisition of the fear response when injected immediately after the training, but not at a later time point.”
Quote in the paperSubstantial claim - Findingown data
CRFR antagonists alone did not affect the behavior of mice in the plus-maze.
“The inefficiency of CRFR antagonists alone to affect the behavior of mice in the plus-maze suggested that hippocampal and septal CRFR did not contribute to a significant extent to the tonic regulation of anxiety by CRF.”
Quote in the paperSubstantial claim - Findingcitation
The dose of h/rCRF required for induction of anxiety-related behavior was higher than the dose that modulated learning.
“In agreement with previous findings (Behan et al., 1995), the dose of h/rCRF required for induction of anxiety-related behavior was higher than the dose that modulated learning.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Behan et al., 1995
Not checked in the free run.
- Findingown data
The dose of h/rCRF required to produce maximal enhancement or impairment of fear conditioning did not affect anxiety.
“The dose of h/rCRF required to produce maximal enhancement or impairment of fear conditioning did not affect anxiety.”
Quote in the paperSubstantial claim - Findingown data
Stress-induced anxious behavior was fully prevented by i.s. injection of anti-Svg-30.
“Stress-induced anxious behavior was fully prevented by i.s.injection of anti-Svg-30.”
Quote in the paperSubstantial claim - Findingown data
Under nonstress conditions, septal and hippocampal CRFR antagonists did not affect anxiety or fear conditioning by themselves.
“The stress-induced increase of anxiety and fear conditioning could be fully prevented by septal and hippocampal CRFR antagonists, respectively, which under nonstress conditions did not affect either behavior by themselves.”
Quote in the paperSubstantial claim - Findingown data
Astressin prevented the effects of stress when given by i.h. application before as well as 3 hr after immobilization.
“Interestingly, astressin prevented the effects of stress when given by i.h.application before as well as 3 hr after immobilization, suggesting that hippocampal CRFR1 was activated biphasically, during stress and 3 hr after termination of the stressful stimulus.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Modulation of Learning and Anxiety by Corticotropin-Releasing Factor (CRF) and Stress: Differential Roles of CRF Receptors 1 and 2
CRF acted on memory consolidation.
“Thus, it was indicated that CRF acted on memory consolidation.”
Quote in the paperSubstantial claim - Premisecitation
Modulation of learning and memory seems to be one of the major roles of CRF in rodent and human brain.
“Modulation of learning and memory seems to be one of the major roles of CRF in rodent and human brain.”
Quote in the paperSubstantial claim - Premisecitation
CRF modulates learning and memory at a low dose that does not affect arousal, locomotion, or anxiety.
“Increasing evidence suggests that these effects are independent of the arousal state, as indicated by the observation that CRF modulates learning and memory at a low dose that does not affect arousal, locomotion, or anxiety (Behan et al., 1995).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Behan et al., 1995
Not checked in the free run.
- Premisecitation
Intracerebroventricular injections of CRF or its displacement from CRF-BP before or immediately after training enhances memory in multiple learning tasks.
“Intracerebroventricular injections of CRF or its displacement from CRF-BP before or immediately after training enhances memory in multiple learning tasks (Koob and Bloom, 1985;Liang and Lee, 1988;Behan et al., 1995, Heinrichs et al., 1997), whereas intracerebroventricular administration before the memory test seems to impair memory (Diamant and De Wied, 1993).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Koob and Bloom, 1985
Not checked in the free run.
- cites Liang and Lee, 1988
Not checked in the free run.
- cites Behan et al., 1995
Not checked in the free run.
- Interpretationcitation
The enhanced freezing by i.h. h/rCRF was not caused by effects on locomotor activity or place aversion.
“indicating that enhanced freezing was not caused by effects of h /rCRF on locomotor activity (Sutton et al., 1982) or place aversion (C ador et al., 1992).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Sutton et al., 1982
Not checked in the free run.
- cites Cador et al., 1992
Not checked in the free run.
- Premisecitation
Decreased time on the open arms and decreased number of open arm entries are believed to reflect anxious behavior.
“Decreased time on the open arms and decreased number of open arm entries are believed to reflect anxious behavior (Dunn and Berridge, 1990;De Souza, 1995).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Dunn and Berridge, 1990
Not checked in the free run.
- cites De Souza, 1995
Not checked in the free run.
- Premisecitation
Anti-Svg-30 preferentially blocks CRFR2.
“In contrast to astressin, a nonselective antagonist for both CRFR1 and 2, anti-Svg-30 was demonstrated to block preferentially CRFR2 (Ru ¨hmann et al., 1998).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rühmann et al., 1998
Not checked in the free run.
- Interpretationown data
The effects observed after i.h. injection of h/rCRF were not caused by peptide leakage into the lateral brain ventricles.
“These results excluded the possibility that the effects observed after i.h.injection of h/rCRF were caused by peptide leakage into the lateral brain ventricles.”
Quote in the paperSubstantial claim - Interpretationown data
The receptor specificity of the CRF effects on fear conditioning was demonstrated for the first time in the present study by using two CRFR antagonists: astressin and anti-Svg-30.
“The receptor specificity of the CRF effects on fear conditioning was demonstrated for the first time in the present study by using two CRFR antagonists: the nonselective antagonist astressin and the selective CRFR2 antagonist anti-Svg-30.”
Quote in the paperSubstantial claim - Interpretationreasoning
Stimulation of CRFR2 had to occur before or during training to affect tone-dependent fear conditioning.
“In view of the inability of h/rCRF to impair conditioning to tone, it was suggested that stimulation of CRFR2 had to occur before or during training to affect tone-dependent fear conditioning.”
Quote in the paperSubstantial claim - Interpretationreasoning
The in vivo interactions of h/rCRF and Ucn with their receptors differed from the ones in vitro.
“Thus, it appears that the in vivo interactions of h/rCRF and Ucn with their receptors differed from the ones in vitro.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Ucn may be the putative ligand for CRFR2.
- Interpretationown data
The modulation of conditioned fear by h/rCRF is specific for learning and not performance.
“Modulation of conditioned fear observed in the present experiments was specific for learning and not performance, as demonstrated by the efficiency of h/rCRF to modulate the acquisition of the fear response when injected immediately after the training, but not at a later time point.”
Quote in the paperSubstantial claim - Interpretationown data
The effect of h/rCRF(6-33) on fear conditioning was mediated by the dorsal hippocampus.
“The results of the i.h.injections demonstrated that this effect was mediated by the dorsal hippocampus.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
- Interpretationcitation
The impairment of contextual fear conditioning by i.s. injection of h/rCRF after training is probably the result of longer processing of contextual stimuli.
“The impairment of contextual fear conditioning by i.s.injection of h/rCRF after the training was probably the result of longer processing of contextual stimuli (Rudy and Morledge, 1994; O. Stiedl and J. Spiess, unpublished observations), which may render this form of conditioning susceptible to modulation over a longer time.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Rudy and Morledge, 1994
Not checked in the free run.
- cites O. Stiedl and J. Spiess, unpublished observations
Not checked in the free run.
- Premisecitation
The CRFR2α and β splice variants share similar ligand-binding properties.
“The ability of anti-Svg-30, originally developed as a CRFR2 antagonist, to prevent the behavioral effect of h/rCRF was consistent with previous data demonstrating that the CRFR2 ␣ and  splice variants share similar ligand-binding properties (Donaldson et al., 1996).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Donaldson et al., 1996
Not checked in the free run.
- Interpretationcitation
The difference between in vivo and in vitro interactions could be explained, at least in part, by the partial agonism of rUcn toward CRFR1.
“Such difference could be explained, at least in part, by the partial agonism of rUcn toward CRFR1 (A.Ru ¨hmann and J. Spiess, unpublished results).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites A. Rühmann and J. Spiess, unpublished results
Not checked in the free run.
- Interpretationreasoning
Impairment of fear conditioning by h/rCRF through the lateral septal area may be mediated by CRFR2.
“These results suggested that impairment of fear conditioning by h/rCRF through the lateral septal area may be mediated by the recently identified CRFR2.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
- Interpretationown data
Learning of aversive stimuli after classic fear conditioning is profoundly and differentially modulated by the hippocampal CRFR1 and septal CRFR2 systems.
“The results from this study demonstrated that learning of aversive stimuli after classic fear conditioning is profoundly and differentially modulated by the hippocampal CRFR1 and septal CRFR2 systems.”
Quote in the paperSubstantial claim - Premisecitation
The hippocampus plays a crucial role in context-dependent fear conditioning.
“Numerous studies, using lesioning (Kim and Fanselow, 1992;Phillips and LeDoux, 1992) and genetic (Aiba et al., 1994;Tsien et al., 1996) strategies, indicated that the hippocampus plays a crucial role in context-dependent fear conditioning.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Kim and Fanselow, 1992
Not checked in the free run.
- cites Phillips and LeDoux, 1992
Not checked in the free run.
- cites Aiba et al., 1994 source
Not checked in the free run.
- Interpretationreasoning
Decreased anxious responses observed with CRFR1-deficient mice could be caused by CRFR1 deficiency in brain areas other than the hippocampus.
“It appears, therefore, that decreased anxious responses recently observed with CRFR1-deficient mice (Smith et al., 1998;Timpl et al., 1998) could be caused by CRFR1 deficiency in brain areas other than the hippocampus.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Smith et al., 1998
Not checked in the free run.
- cites Timpl et al., 1998
Not checked in the free run.
- Interpretationreasoning
Enhancement of context-dependent fear observed after injection of CRF-like peptides into the CA1 area is consistent with the view that the hippocampus plays a crucial role in context-dependent fear conditioning.
“Thus, enhancement of context-dependent fear, observed after injection of CRF-like peptides into the CA1 area, was consistent with this view.”
Quote in the paperSubstantial claim - Interpretationown data
Septal CRFR2 has a role in anxiety generated by pharmacological or stress-induced increase of CRF activity.
“Thus, an additional novel role of septal CRFR2 was demonstrated in anxiety generated by pharmacological or stress-induced increase of CRF activity.”
Quote in the paperSubstantial claim- Rests on an assumption: Immobilization stress increases endogenous CRF activity in the brain areas studied.
- Interpretationreasoning
Hippocampal and septal CRFR did not contribute to a significant extent to the tonic regulation of anxiety by CRF.
“The inefficiency of CRFR antagonists alone to affect the behavior of mice in the plus-maze suggested that hippocampal and septal CRFR did not contribute to a significant extent to the tonic regulation of anxiety by CRF.”
Quote in the paperSubstantial claim - Interpretationown data
The role of the endogenous CRF system in learning and anxiety strongly depends on the brain area, receptor type, and previous stressful experiences.
“The presented data indicate that the role of the endogenous CRF system in learning and anxiety strongly depends on the brain area, receptor type, and previous stressful experiences.”
Quote in the paperSubstantial claim- Rests on an assumption: Immobilization stress increases endogenous CRF activity in the brain areas studied.
- Interpretationown data
CRFR-mediated effects are potentiated after stress.
“These results, demonstrating potentiation of CRFR-mediated effects after stress, are consistent with increasing recent evidence suggesting that the glucocorticoid hormones lower the threshold for CRF actions in the limbic system (Schulkin et al., 1998).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Schulkin et al., 1998
Not checked in the free run.
- Rests on an assumption: Immobilization stress increases endogenous CRF activity in the brain areas studied.
- Interpretationreasoning
The existence of two receptors mediating opposite effects under different conditions provides the CRF system with a high flexibility and a dynamic role in the plastic adaptation of the CNS to environmental challenge.
“Thus the existence of two receptors mediating opposite effects under different conditions provides the CRF system with a high flexibility and a dynamic role in the plastic adaptation of the C NS to environmental challenge.”
Quote in the paperSubstantial claim- Rests on an assumption: Immobilization stress increases endogenous CRF activity in the brain areas studied.
- Interpretationreasoning
The brain CRF systems may subserve different roles in the processing of sensory information generated by stimuli of different biological significance.
“However, impairment of learning through septal CRFR2 under baseline conditions and enhancement of learning through hippocampal CRFR1 after stress demonstrated that the brain CRF systems may subserve different roles in the processing of sensory information generated by stimuli of different biological significance.”
Quote in the paperSubstantial claim- Rests on an assumption: Immobilization stress increases endogenous CRF activity in the brain areas studied.
- Interpretationown data
Hippocampal CRFR1 was activated biphasically, during stress and 3 hr after termination of the stressful stimulus.
“Interestingly, astressin prevented the effects of stress when given by i.h.application before as well as 3 hr after immobilization, suggesting that hippocampal CRFR1 was activated biphasically, during stress and 3 hr after termination of the stressful stimulus.”
Quote in the paperSubstantial claim- Rests on an assumption: Immobilization stress increases endogenous CRF activity in the brain areas studied.
- Interpretationreasoning
CRF actions mediated through septal CRFR2 and hippocampal CRFR1 are differentially affected by stress.
“The different time course of stress-induced facilitation of anxious behavior and fear conditioning suggests that the CRF actions mediated through septal CRFR2 and hippocampal CRFR1 are differentially affected by stress.”
Quote in the paperSubstantial claim- Rests on an assumption: Immobilization stress increases endogenous CRF activity in the brain areas studied.
- May combine two claims. 27
- Classified as probably not a substantial claim. 5
May combine two claims.
Findingown data§ Modulation of Learning and Anxiety by Corticotropin-Releasing Factor (CRF) and Stress: Differential Roles of CRF Receptors 1 and 2Injection of CRF after training into the dorsal hippocampus enhanced learning, and into the lateral intermediate septum impaired learning.
“Injection of CRF after the training into the dorsal hippocampus and the lateral intermediate septum also enhanced and impaired learning, respectively.”
- Also stated in: § Modulation of fear conditioning by h/rCRF is restricted to a small time window · plain
“i.h.administration of h/rCRF immediately after the training also enhanced acquisition of context-dependent (F (5,48) ϭ 9.568, p Ͻ 0.001) and tonedependent fear (F (5,48) ϭ 9.344, p Ͻ 0.001) (Fig. 5a).”
- Also stated in: § Modulation of fear conditioning by h/rCRF is restricted to a small time window · plain
“Context-dependent fear was impaired by i.s.injection of h/rCRF before and immediately after the training, whereas injection 1 hr after the training was ineffective.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
- Also stated in: § Modulation of fear conditioning by h/rCRF is restricted to a small time window · plain
May combine two claims.
Findingown data§ Modulation of Learning and Anxiety by Corticotropin-Releasing Factor (CRF) and Stress: Differential Roles of CRF Receptors 1 and 2A dose of 20 pmol human/rat CRF was sufficient to affect learning significantly, but a fivefold higher dose was required to induce anxiety by injection into the septum.
“Although a dose of 20 pmol human/rat CRF was sufficient to affect learning significantly, a fivefold higher dose was required to induce anxiety by injection into the septum.”
- Also stated in: § h/rCRF induces anxious behavior through septal CRFR2 but not hippocampal CRFR1 · plain
“The dose of h /rCRF modulating fear conditioning did not affect plus-maze behavior (Fig. 7), as evaluated by time spent, number of entries, and distance crossed on the open and closed arms of an elevated plus-maze.However, i.s.injection of 500 ng h /rCRF per mouse significantly reduced the time spent (F (4,45) ϭ 4.32, p Ͻ 0.01) (Fig. 7a) and the number of entries (F (4,45) ϭ 4.11, p Ͻ 0.01) (Fig.”
Quote in the paperSubstantial claim- Also stated in: § h/rCRF induces anxious behavior through septal CRFR2 but not hippocampal CRFR1 · plain
May combine two claims.
Findingown data§ Modulation of Learning and Anxiety by Corticotropin-Releasing Factor (CRF) and Stress: Differential Roles of CRF Receptors 1 and 2Immobilization for 1 hr generated a stress response that included induction of anxiety through septal CRFR2 and subsequent enhancement of learning through hippocampal CRFR1.
“Immobilization for 1 hr generated a stress response that included the induction of anxiety through septal CRFR2 and the subsequent enhancement of learning through hippocampal CRFR1.”
- Also stated in: § h/rCRF mediates stress-induced enhancement of fear conditioning through hippocampal CRFR1 and stressinduced anxiety through septal CRFR2 · plain
“In mice subjected to 1 hr immobilization stress, fear conditioning to context ((F 3,40 ϭ 7.134, p Ͻ 0.01) and tone (F 3,40 ϭ 6.795, p Ͻ 0.01) was significantly increased 3 hr after termination of the stress when compared with nonstressed controls (Fig. 8a).”
- Also stated in: § h/rCRF mediates stress-induced enhancement of fear conditioning through hippocampal CRFR1 and stressinduced anxiety through septal CRFR2 · plain
“Astressin and anti-SVG-30 completely prevented stress-induced anxiety when given by i.s.injection (Fig. 9c,d) but not by i.h.injection (data not shown) before the immobilization stress.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
- Also stated in: § h/rCRF mediates stress-induced enhancement of fear conditioning through hippocampal CRFR1 and stressinduced anxiety through septal CRFR2 · plain
May combine two claims.
Findingown dataEnhancement of freezing by i.h. injection of h/rCRF was demonstrated only for fear-conditioned mice, not for mice receiving peptide without a shock.
“Enhancement of freezing by i.h.injection of h/rCRF was demonstrated only for fear-conditioned mice, but not for mice receiving peptide without a shock (Fig. 2a)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataLocomotor activity and shock response did not differ between mice injected with CRF-like peptides and control mice injected with aCSF.
“The locomotor activities and the activity burst in response to the shock of mice injected with CRF-like peptides did not differ from the values of control mice injected with aCSF (data not shown).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe minimally required dose for modulation of fear conditioning after local administration of h/rCRF was 25 ng per injection site (50 ng total), a dose ineffective after intracerebroventricular injection.
“The minimally required dose for modulation of fear conditioning after local administration of h /rCRF was 25 ng per injection site [a total of 50 ng (10 pmol) per mouse], a dose ineffective after intracerebroventricular injection of h /rCRF.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datai.h. administration of h/rCRF enhanced context-dependent and tone-dependent fear, whereas i.s. administration impaired them, in a dose-dependent manner.
“Subsequent experiments demonstrated that i.h.administration of h/rCRF enhanced context-dependent (F (3,35) ϭ 9.726, p Ͻ 0.001) and tone-dependent fear (F (3,35) ϭ 9.456, p Ͻ 0.001) (Fig. 3a), whereas i.s.administration of h/rCRF impaired context-dependent (F (3,31) ϭ 8.120, p Ͻ 0.001) (Fig. 4a) and tone-dependent fear (F (3,31) ϭ 7.724, p Ͻ 0.001) (Fig. 4b) in a dose-dependent manner.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
May combine two claims.
Findingown dataThe enhancement of fear conditioning after i.h. injection of h/rCRF was completely blocked by previous administration of astressin but not antisauvagine-30.
“The enhancement of fear conditioning after i.h.injection of h/rCRF was completely blocked by previous administration of astressin but not antisauvagine-30 (anti-Svg-30) (Fig. 6a), a peptidic antagonist recently developed in our laboratory (Ru ¨hmann et al., 1998).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rühmann et al., 1998
Not checked in the free run.
May combine two claims.
Findingown dataAdministration of astressin and anti-Svg-30 alone into the hippocampus did not affect fear conditioning, whereas their i.s. injection significantly enhanced fear conditioning to context and tone.
“Administration of the CRF receptor antagonists astressin and anti-Svg-30 alone into the hippocampus did not affect fear conditioning, whereas their i.s.injection significantly enhanced fear conditioning to context (F (5,42) ϭ 12.089, p Ͻ 0.001) and tone (F (5,42) ϭ 11.664, p Ͻ 0.001).”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
May combine two claims.
Findingown dataAstressin and anti-Svg-30 applied by i.s. injection completely antagonized anxiety induced by i.s. injection of h/rCRF without affecting baseline anxiety levels.
“Astressin and anti-Svg-30 applied by i.s.injection completely antagonized anxiety induced by i.s.injection of h/rCRF (Fig. 7a,b), without affecting baseline anxiety levels.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAstressin and anti-SVG-30 completely prevented stress-induced anxiety when given by i.s. injection but not by i.h. injection before the immobilization stress.
“Astressin and anti-SVG-30 completely prevented stress-induced anxiety when given by i.s.injection (Fig. 9c,d) but not by i.h.injection (data not shown) before the immobilization stress.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
May combine two claims.
Findingown datai.s. injection of 500 ng h/rCRF per mouse significantly reduced the time spent and the number of entries on the open arms without affecting locomotor activity.
“However, i.s.injection of 500 ng h /rCRF per mouse significantly reduced the time spent (F (4,45) ϭ 4.32, p Ͻ 0.01) (Fig. 7a) and the number of entries (F (4,45) ϭ 4.11, p Ͻ 0.01) (Fig. 7b) on the open arms without affecting locomotor activity (data not shown), as revealed by the total distance crossed in 5 min.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCRF-injected mice exhibited strong freezing to the context and tone used as conditioned stimuli, but this fear response did not generalize to a novel context.
“The specific action of CRF on learning was also supported by the observation that CRF-injected mice exhibited strong freezing to the context and tone used as conditioned stimuli, but this fear response did not generalize to a novel context.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataExposure of mice to immobilization stress produced transiently increased anxiety after 30 min that disappeared after 1 hr, followed by enhanced acquisition of conditioned fear after 3 hr.
“Exposure of mice to immobilization stress produced sequential changes in anxiety and learning, as shown by a transiently increased anxiety after 30 min that disappeared after 1 hr, followed by enhanced acquisition of conditioned fear after 3 hr.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe stress-induced increase of anxiety and fear conditioning could be fully prevented by septal and hippocampal CRFR antagonists, respectively.
“The stress-induced increase of anxiety and fear conditioning could be fully prevented by septal and hippocampal CRFR antagonists, respectively, which under nonstress conditions did not affect either behavior by themselves.”
Quote in the paperSubstantial claim- Rests on an assumption: Immobilization stress increases endogenous CRF activity in the brain areas studied.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenA role of CRFR2 and a relationship between CRFR1- and CRFR2-mediated behaviors of the brain CRF system have not been established.
“So far, a role of CRFR2 and a relationship between CRFR1-and CRFR2-mediated behaviors of the brain CRF system have not been established.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown data§ Modulation of Learning and Anxiety by Corticotropin-Releasing Factor (CRF) and Stress: Differential Roles of CRF Receptors 1 and 2The observed effects reflected changes of associative learning and not arousal, attention, or motivation.
“It was concluded that the observed effects reflected changes of associative learning and not arousal, attention, or motivation.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationCRF and Ucn exert their biological activity by binding to two types of CRF receptors, CRFR1 and CRFR2, which show distinct distribution patterns in specific brain areas.
“CRF and Ucn exert their biological activity by binding to two types of CRF receptors (CRFRs), CRFR1 (Chen et al., 1993;Chang et al., 1993;Vita et al., 1993;Dautzenberg et al., 1998) and CRFR2 (L ovenberg et al., 1995;Perrin et al., 1995;Stenzel et al., 1995;K ishimoto et al., 1995), which show distinct distribution patterns in specific brain areas (Chalmers et al., 1995).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Chen et al., 1993
Not checked in the free run.
- cites Lovenberg et al., 1995
Not checked in the free run.
- cites Chalmers et al., 1995
Not checked in the free run.
May combine two claims.
PremisecitationHigher doses of CRF typically induce anxiety, whereas displacement of CRF from its binding protein even by high doses of CRF-BP ligands enhances learning without affecting anxiety.
“Interestingly, higher doses of CRF typically induce anxiety, whereas displacement of CRF from its binding protein even by high doses of CRF-BP ligands enhances learning without affecting anxiety (Dunn and Berridge, 1990;Behan et al., 1995).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Dunn and Berridge, 1990
Not checked in the free run.
- cites Behan et al., 1995
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCRF and Ucn are widely distributed throughout the CNS of rodents and humans, where they affect numerous behaviors such as locomotor activity, anxiety, food intake, and learning.
“In addition, CRF and the novel CRF-like peptide urocortin (Ucn) are widely distributed throughout the C NS of rodents and humans (Olschowka et al., 1982;Cummings et al., 1983;Vaughan et al., 1995;Kozicz et al., 1998), where they affect numerous behaviors such as locomotor activity, anxiety, food intake, and learning (Sutton et al., 1982;Dunn and Berridge, 1990;De Souza, 1995).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Olschowka et al., 1982
Not checked in the free run.
- cites Vaughan et al., 1995
Not checked in the free run.
- cites Dunn and Berridge, 1990
Not checked in the free run.
May combine two claims.
PremisecitationThe hippocampus is required for context-dependent and tone-dependent fear conditioning.
“The hippocampus appears to be required for context-dependent (Kim and Fanselow, 1992;Phillips and LeDoux, 1992) and tonedependent fear conditioning (Maren et al., 1997)”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Kim and Fanselow, 1992
Not checked in the free run.
- cites Phillips and LeDoux, 1992
Not checked in the free run.
- cites Maren et al., 1997
Not checked in the free run.
May combine two claims.
PremisecitationThe lateral septum mediates the impairment of conditioned fear responses and the enhancement of anxious behaviors.
“whereas the lateral septum mediates the impairment of conditioned fear responses (Thomas and Yadin, 1980;Yadin and Thomas, 1981; Garcia and Jaffard, 1996) and the enhancement of anxious behaviors (Menard and Treit, 1996).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Thomas and Yadin, 1980
Not checked in the free run.
- cites Yadin and Thomas, 1981
Not checked in the free run.
- cites Garcia and Jaffard, 1996
Not checked in the free run.
May combine two claims.
InterpretationreasoningFear conditioning was tonically impaired by septal CRFR2 but not by hippocampal CRFR1.
“Thus, these antagonists exhibited an effect opposite to the one of h /rCRF and suggested that fear conditioning was tonically impaired by septal CRFR2 but not by hippocampal CRFR1.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
May combine two claims.
InterpretationreasoningPost-training i.h. injection of h/rCRF increases fear conditioning, and this effect excludes attentional, motivational, or arousal effects.
“The effect of post-training i.h.injection of h/rCRF to increase fear conditioning excluded the possibility that the observed effect was caused by attentional, motivational, or arousal effects.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataControl experiments demonstrated that the effects were specifically mediated through the dorsal hippocampus and lateral intermediate septum but not through neighboring brain areas or lateral ventricles.
“Control experiments demonstrated that these effects were specifically mediated through the dorsal hippocampus and lateral intermediate septum but not through the neighboring brain areas or lateral ventricles.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hippocampus and lateral intermediate septum play an important role in associative learning.
May combine two claims.
PremisecitationHigh levels of CRFR2α mRNA but not CRFR1 mRNA or CRFR1 protein were found in the lateral intermediate septum.
“In agreement with this observation, high levels of CRFR2␣ mRNA but not CRFR1 mRNA (Chalmers et al., 1995) or CRFR1 protein (Radulovic et al., 1998a) were found in the lateral intermediate septum.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Chalmers et al., 1995
Not checked in the free run.
- cites Radulovic et al., 1998a
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationA recent study reported impairment of tone-dependent fear conditioning after neurotoxic and electrolytic lesions of the dorsal hippocampus.
“It should be mentioned, however, that a recent study reported impairment of tone-dependent fear conditioning after neurotoxic and electrolytic lesions of the dorsal hippocampus (Maren et al., 1997), a region used for CRF-like peptide injections in our experiments.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Maren et al., 1997
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationcitationEnhanced associative learning of tone-dependent fear through hippocampal CRFR1 could result from activation of hippocampal pathways to the amygdala.
“Enhanced associative learning of tone-dependent fear through hippocampal CRFR1 could result from activation of hippocampal pathways to the amygdala (Henke, 1990), a brain region identified as being crucial for acquisition of fear responses.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Henke, 1990 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningEnhancement of tone-dependent fear contrasted with the common view that the hippocampal formation does not play a role in acquisition of tone-dependent fear.
“However, enhancement of tonedependent fear, generally believed to be mediated by different neuronal circuits, contrasted with the common view that the hippocampal formation does not play a role in acquisition of tone-dependent fear.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe high density of glucocorticoid receptors and almost restricted distribution of mineralocorticoid receptors was demonstrated in the lateral septum and hippocampus.
“Consistently, the high density of glucocorticoid receptors and almost restricted distribution of mineralocorticoid receptors was demonstrated in the lateral septum and hippocampus (Reul and De Kloet, 1985).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Reul and De Kloet, 1985
Not checked in the free run.
The authors state this as an assumption.
The hippocampus and lateral intermediate septum play an important role in associative learning.
“These two regions, which contain different amounts of CRFR1, CRFR2, and CRF-BP, are assumed to play an important role in associative learning.”
The authors state this as an assumption.
Ucn may be the putative ligand for CRFR2.
“The observation that h/rCRF was more effective than Ucn in enhancing or impairing fear conditioning was surprising in view of the assumption that Ucn may be the putative ligand for CRFR2 and the finding that Ucn binds under defined conditions with higher affinity than h/rCRF to both CRFR1 and CRFR2 (Vaughan et al., 1995).”
The paper relies on this without support.
Immobilization stress increases endogenous CRF activity in the brain areas studied.
“The stress-induced increase of anxiety and fear conditioning could be fully prevented by septal and hippocampal CRFR antagonists, respectively, which under nonstress conditions did not affect either behavior by themselves.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LS injections of agonists of the type 2 corticotropin-releasing factor receptor (Crfr2) have resulted in increased anxiety.
“For example, LS injections of agonists of the type 2 corticotropin-releasing factor receptor (Crfr2) have resulted in increased anxiety (Radulovic et al., 1999; Bakshi et al., 2002; Henry et al., 2006).”
From Control of Stress-Induced Persistent Anxiety by an Extra-Amygdala Septohypothalamic Circuit (2014) · cites this paper as Radulovic et al., 1999
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Fear-conditioning result is attributed to the anatomical figure
MinorThe text cites Figure 1a for the context-dependent fear-conditioning result, but the Figure 1 caption identifies it as showing injection-site anatomy. The Figure 2 caption identifies panel a as the context-dependent fear-conditioning result.
“fear conditioning to both context, F (12,103) ϭ 5.158, p Ͻ 0.001 (Fig. 1a)”
“Figure 1.Anatomical localization of the injection sites for CRF receptor agonists and antagonists.”
Intracaudate panel has conflicting labels
MinorThe results refer to panels 3c and 3d for the cortical and striatal injections, respectively, whereas the Figure 3 caption labels the intracaudate panel e.
“Injection of CRF-like peptides into the parietal somatosensory cortex and striatum, brain regions adjacent to the hippocampus and septum, respectively, did not produce any significant effects on contextand tone-dependent fear conditioning (Fig. 3c,d).”
“Context-and tone-dependent fear conditioning after i.h. ( a), i.s. ( b), intracortical ( c), or intracaudate ( e) injection of 20 pmol peptide per mouse.”
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859 · see citing works
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · see citing works
Self-citationVale, W., Spiess, J., RIVIER, C. L., & Rivier, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904 · see citing works
Self-citationDifferential contribution of amygdala and hippocampus to cued and contextual fear conditioning.
Phillips, R. G., & LeDoux, J. E. (1992) · Behavioral Neuroscience · doi:10.1037/0735-7044.106.2.274 · Cited by 3,292 · see citing works
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.
Phillips, R. G., & LeDoux, J. E. (1992) · Behavioral Neuroscience · doi:10.1037//0735-7044.106.2.274 · Cited by 3,262 · see citing works
Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation
REUL, J. M. H. M., & KLOET, E. R. D. (1985) · Endocrinology · doi:10.1210/endo-117-6-2505 · Cited by 2,580 · see citing works
Modality-Specific Retrograde Amnesia of Fear
Kim, J. J., & Fanselow, M. S. (1992) · Science · doi:10.1126/science.1585183 · Cited by 2,483 · see citing works
The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory.
Tsien, J. Z., Huerta, P. T., & Tonegawa, S. (1996) · Cell · doi:10.1016/s0092-8674(00)81827-9 · Cited by 1,782 · cited 1× · see citing works
“Numerous studies, using lesioning (Kim and Fanselow, 1992; Phillips and LeDoux, 1992) and genetic (Aiba et al., 1994; Tsien et al., 1996) strategies, indicated that the hippocampus plays a crucial role in context-dependent fear conditioning.”
BackgroundVaughan, J. M., Donaldson, C. J., Bittencourt, J. C., Perrin, M. H., Lewis, K., Sutton, S. W., Chan, R. K. W., Turnbull, A. V., Lovejoy, D. A., RIVIER, C. L., et al. (1995) · Nature · doi:10.1038/378287a0 · Cited by 1,479 · see citing works
Smith, M., Makino, S., Květňanský, R., & Post, R. M. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01768.1995 · Cited by 1,429 · see citing works
Dunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352 · see citing works
Chalmers, D., Lovenberg, T. W., & Souza, E. D. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06340.1995 · Cited by 925 · see citing works
Expression cloning of a human corticotropin-releasing-factor receptor.
Chen, R., Lewis, K. A., Perrin, M. H., & Vale, W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8967 · Cited by 925 · see citing works
Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., & Wurst, W. (1998) · Nature Genetics · doi:10.1038/520 · Cited by 919 · see citing works
Smith, G. W., Aubry, J.-M., Dellu, F., Contarino, A., Bilezikjian, L. M., Gold, L. H., Chen, R., Marchuk, Y., Hauser, C., Bentley, C. A., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80491-2 · Cited by 892 · see citing works
Lovenberg, T. W., Liaw, C. W., Grigoriadis, D. E., Clevenger, W., Chalmers, D. T., Souza, E. B. D., & Oltersdorf, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.836 · Cited by 846 · see citing works
Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats
Maren, S., Aharonov, G., & Fanselow, M. S. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00088-0 · Cited by 765 · see citing works
Corticotropin releasing factor produces behavioural activation in rats
Sutton, R., Koob, G., le Moal, M., Rivier, J., & Vale, W. (1982) · Nature · doi:10.1038/297331a0 · Cited by 744 · see citing works
Aiba, A. (1994) · Cell · doi:10.1016/0092-8674(94)90204-6 · Cited by 614 · see citing works
Chang, C.-P., Pearse, R. V., O'Connell, S., & Rosenfeld, M. G. (1993) · Neuron · doi:10.1016/0896-6273(93)90230-o · Cited by 537 · see citing works
Perrin, M. H., Donaldson, C. J., Chen, R., Blount, A. L., Berggren, T., Bilezikjian, L. M., Sawchenko, P. E., & Vale, W. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2969 · Cited by 502 · see citing works
Primary structure of corticotropin-releasing factor from ovine hypothalamus
Spiess, J., Rivier, J., Rivier, C., & Vale, W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6517 · Cited by 424 · see citing works
Self-citationSchulkin, J., W. Gold, P., & S. McEwen, B. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00099-1 · Cited by 423 · see citing works
Cummings, S., Elde, R., Ells, J., & Lindall, A. (1983) · Journal of Neuroscience · doi:10.1523/jneurosci.03-07-01355.1983 · Cited by 414 · see citing works
Souza, E. B. D. (1995) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00011-9 · Cited by 397 · see citing works
A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle.
Kishimoto, T., Pearse, R. V., Lin, C. R., & Rosenfeld, M. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1108 · Cited by 372 · see citing works
Cloning and characterization of human urocortin.
Donaldson, C. J., Sutton, S. W., Perrin, M. H., CORRIGAN, A. Z., Lewis, K. A., Rivier, J., Vaughan, J. M., & Vale, W. (1996) · Endocrinology · doi:10.1210/endo.137.5.8612563 · Cited by 371 · see citing works
Potter, E., Behan, D. P., Fischer, W. H., Linton, E. A., Lowry, P. J., & Vale, W. (1991) · Nature · doi:10.1038/349423a0 · Cited by 357 · see citing works
Vita, N., Laurent, P., Lefort, S., Chalon, P., Lélias, J.-M., Kaghad, M., Fur, G. L., Caput, D., & Ferrara, P. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80427-v · Cited by 323 · see citing works
Corticotropin-releasing factor and behavior.
Koob, G. F., & Bloom, F. E. (1985) · PubMed · Cited by 292 · see citing works
Potter, E., Behan, D. P., Linton, E. A., Lowry, P. J., Sawchenko, P. E., & Vale, W. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4192 · Cited by 285 · see citing works
The distribution of corticotropin releasing factor-like immunoreactive neurons in rat brain
Olschowka, J. A., O’Donohue, T. L., Mueller, G. P., & Jacobowitz, D. M. (1982) · Peptides · doi:10.1016/0196-9781(82)90071-7 · Cited by 277 · see citing works
Behan, D., Heinrichs, S., Troncoso, J., Liu, X.-J., Kawas, C., Ling, N., & de Souza, E. D. (1995) · Nature · doi:10.1038/378284a0 · Cited by 248 · see citing works
Radulović, J., Kammermeier, J., & Spiess, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07452.1998 · Cited by 245 · see citing works
Self-citationRudy, J. W., & Morledge, P. (1994) · Behavioral Neuroscience · doi:10.1037//0735-7044.108.2.227 · Cited by 245 · see citing works
Shintani, F., Nakaki, T., Kanba, S., Sato, K., Yagi, G., Shiozawa, M., Aiso, S., Kato, R., & Asai, M. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01961.1995 · Cited by 245 · see citing works
Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart
Stenzel, P., Kesterson, R. A., Yeung, W., Cone, R. D., Rittenberg, M. B., & Stenzel‐Poore, M. P. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.5.7565810 · Cited by 234 · see citing works
Rudy, J. W., & Morledge, P. (1994) · Behavioral Neuroscience · doi:10.1037/0735-7044.108.2.227 · Cited by 207 · see citing works
Donaldson, C. J. (1996) · Endocrinology · doi:10.1210/en.137.5.2167 · Cited by 183 · see citing works
Liang, K., & Lee, E. H. Y. (1988) · Psychopharmacology · doi:10.1007/bf00177566 · Cited by 174 · see citing works
Rühmann, A., Bonk, I., Lin, C. R., Rosenfeld, M. G., & Spiess, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15264 · Cited by 170 · see citing works
Self-citationHippocampal pathway to the amygdala and stress ulcer development.
Henke, P. G. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90044-z · Cited by 153 · see citing works
Corticotropin releasing factor, stress and behavior
Koob, G. F., Heinrichs, S. C., Menzaghi, F., Pich, E. M., & Britton, K. T. (1994) · Seminars in Neuroscience · doi:10.1006/smns.1994.1029 · Cited by 141 · see citing works
Lateral and Medial Septal Lesions Reduce Anxiety in the Plus-Maze and Probe-Burying Tests
Menard, J. L., & Treit, D. (1996) · Physiology & Behavior · doi:10.1016/0031-9384(96)00138-2 · Cited by 140 · see citing works
Radulović, J., Kammermeier, J., & Spiess, J. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(98)00039-4 · Cited by 125 · see citing works
Self-citationGlazner, G. W., Mu, X., & Springer, J. E. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980202)391:1 · Cited by 110 · see citing works
Effect of tone-dependent fear conditioning on heart rate and behavior of C57BL/6N mice.
Stiedl, O., & Spiess, J. (1997) · Behavioral Neuroscience · doi:10.1037//0735-7044.111.4.703 · Cited by 109 · see citing works
Self-citationEffect of tone-dependent fear conditioning on heart rate and behavior of C57BL/6N mice.
Stiedl, O., & Spiess, J. (1997) · Behavioral Neuroscience · doi:10.1037/0735-7044.111.4.703 · Cited by 95 · see citing works
Self-citationCorticotropin-releasing factor induces a place aversion independent of its neuroendocrine role
Cador, M., Ahmed, S. H., Koob, G. F., Le Moal, M., & Stinus, L. (1992) · Brain Research · doi:10.1016/0006-8993(92)91487-y · Cited by 74 · see citing works
Septal correlates of conditioned inhibition and excitation in rats.
Yadin, E., & Thomas, E. (1981) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0077769 · Cited by 52 · see citing works
Dautzenberg, F. M., Wille, S., Lohmann, R., & Spiess, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4941 · Cited by 52 · see citing works
Self-citationBehan, D. P., Khongsaly, O., Ling, N., & Souza, E. B. D. (1996) · Brain Research · doi:10.1016/0006-8993(96)00347-2 · Cited by 52 · see citing works
Heinrichs, S. C., Vale, E. A., Lapsansky, J., Behan, D. P., McClure, L. V., Ling, N. C., Souza, E. B. D., & Schulteis, G. (1997) · Peptides · doi:10.1016/s0196-9781(97)00120-4 · Cited by 52 · see citing works
Garcia, R., & Jaffard, R. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01266.x · Cited by 39 · see citing works
Lateral and Medial Septal Lesions Reduce Anxiety in the Plus-Maze and Probe-Burying Tests
Menard, J. L. (1996) · Physiology & Behavior · doi:10.1016/s0031-9384(96)00138-2 · Cited by 38 · see citing works
Rühmann, A., Köpke, A. K. E., Dautzenberg, F. M., & Spiess, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10609 · Cited by 37 · see citing works
Self-citationMicroglial activation induced by factor(s) contained in sera from Alzheimer-related ApoE genotypes
Lombardi, V., Garc�a, M., & Cacabelos, R. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981115)54:4 · Cited by 35 · see citing works
Self-citationDiamant, M., & de Wied, D. (2008) · Neuroendocrinology · doi:10.1159/000126473 · Cited by 32 · see citing works
Thomas, E., & Yadin, E. (1980) · Experimental Neurology · doi:10.1016/0014-4886(80)90142-9 · Cited by 16 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181 · see citing works
Neuronal circuits for fear and anxiety
Tovote, P., Fadok, J. P., & Lüthi, A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3945 · Cited by 1,786 · see citing works
HDAC2 negatively regulates memory formation and synaptic plasticity
Guan, J.-S., Haggarty, S. J., Giacometti, E., Dannenberg, J.-H., Joseph, N., Gao, J., Nieland, T. J. F., Zhou, Y., Wang, X., Mazitschek, R., et al. (2009) · Nature · doi:10.1038/nature07925 · Cited by 1,644 · see citing works
Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,488 · see citing works
“…startle might reflect effects on either conditioning or expression, as the effects of CRF receptor antagonists on fear learning and consolidation have previously been noted in mice (Radulovic et al, 1999; Todorovic et al, 2007), although in these studies the lateral septum was also involved.”
BackgroundCRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270 · see citing works
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 963 · see citing works
Neuroendocrine pharmacology of stress
Carrasco, G. A., & Van de Kar, L. D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01285-8 · Cited by 914 · see citing works
Maier, S. F., & Watkins, L. R. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.021 · Cited by 737 · see citing works
Stress and Memory: Behavioral Effects and Neurobiological Mechanisms
Sandi, C., & Pinelo-Nava, M. T. (2007) · Neural Plasticity · doi:10.1155/2007/78970 · Cited by 611 · see citing works
A role for corticotropin releasing factor and urocortin in behavioral responses to stressors
Koob, G. F., & Heinrichs, S. C. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01991-5 · Cited by 530 · see citing works
Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression
Reul, J. M. H. M. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00117-5 · Cited by 515 · see citing works
Regulation of affect by the lateral septum: implications for neuropsychiatry
Sheehan, T. P., Chambers, R. A., & Russell, D. S. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.04.009 · Cited by 514 · see citing works
Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2
Kishimoto, T., Radulović, J., Radulović, M., Lin, C. R., Schrick, C., Hooshmand, F., Hermanson, O., Rosenfeld, M. G., & Spiess, J. (2000) · Nature Genetics · doi:10.1038/74271 · Cited by 502 · see citing works
Self-citationAbnormalities in Hippocampal Functioning with Persistent Pain
Mutso, A., Radzicki, D., Baliki, M. N., Huang, L. Q., Banisadr, G., Centeno, M. V., Radulović, J., Martina, M., Miller, R. J., & Apkarian, A. V. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0587-12.2012 · Cited by 495 · see citing works
The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y
Kask, A., Harro, J., von Hörsten, S., Redrobe, J. P., Dumont, Y., & Quirion, R. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00066-5 · Cited by 358 · see citing works
Corticotropin-Releasing Factor in Brain: A Role in Activation, Arousal, and Affect Regulation
Heinrichs, S. C., & Koob, G. F. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052092 · Cited by 353 · see citing works
Erb, S. M., & Stewart, J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-20-j0006.1999 · Cited by 347 · see citing works
Hauger, R., Risbrough, V. B., Brauns, O., & Dautzenberg, F. M. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706777950684 · Cited by 341 · see citing works
Serotonin and brain development
Sodhi, M., & Sanders‐Bush, E. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)59006-2 · Cited by 337 · see citing works
Corticotropin-releasing hormone receptor subtypes and emotion
Steckler, T., & Holsboer, F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00170-5 · Cited by 323 · see citing works
Control of Stress-Induced Persistent Anxiety by an Extra-Amygdala Septohypothalamic Circuit
Anthony, T. E., Dee, N., Bernard, A., Lerchner, W., Heintz, N., & Anderson, D. J. (2014) · Cell · doi:10.1016/j.cell.2013.12.040 · Cited by 310 · see citing works
A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze
Korte, S. M., & de Boer, S. F. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01279-2 · Cited by 293 · see citing works
Bale, T. L., Picetti, R., Contarino, A., Koob, G. F., Vale, W., & Lee, K. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00193.2002 · Cited by 293 · see citing works
Wigger, A., Sánchez, M. M., Mathys, K. C., Ebner, K., Frank, E., Liu, D., Kresse, A. E., Neumann, I. D., Holsboer, F., Plotsky, P. M., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300290 · Cited by 263 · see citing works
Roozendaal, B., Brunson, K. L., Holloway, B. L., McGaugh, J. L., & Baram, T. Z. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212504599 · Cited by 258 · see citing works
Region-specific roles of the corticotropin-releasing factor–urocortin system in stress
Henckens, M. J. A. G., Deussing, J. M., & Chen, A. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.94 · Cited by 245 · see citing works
Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: Ancient CRF paralogs
Fekete, É. M., & Zorrilla, E. P. (2006) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.09.002 · Cited by 244 · see citing works
Li, C., Vaughan, J. M., Sawchenko, P. E., & Vale, W. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00991.2002 · Cited by 241 · see citing works
Role of corticotropin releasing factor in anxiety disorders: A translational research perspective
Risbrough, V. B., & Stein, M. B. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.06.019 · Cited by 237 · see citing works
Parfitt, G. M., Nguyen, R., Bang, J. Y., Aqrabawi, A. J., Tran, M. M., Seo, D. K., Richards, B. A., & Kim, J. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.56 · Cited by 229 · see citing works
Fear-enhancing effects of septal oxytocin receptors
Guzmán, Y. F., Tronson, N. C., Jovasevic, V., Sato, K., Guedea, A. L., Mizukami, H., Nishimori, K., & Radulovic, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3465 · Cited by 215 · see citing works
Behavioral effects of neuropeptides in rodent models of depression and anxiety
Rotzinger, S., Lovejoy, D. A., & Tan, L. A. (2010) · Peptides · doi:10.1016/j.peptides.2009.12.015 · Cited by 211 · see citing works
Blank, T., Nijholt, I. M., Eckart, K., & Spiess, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03788.2002 · Cited by 210 · see citing works
Self-citationSahuque, L. L., Kullberg, E. F., Mcgeehan, A. J., Kinder, J. R., Hicks, M. P., Blanton, M. G., Janak, P. H., & Olive, M. F. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0362-y · Cited by 207 · see citing works
Localization of glucocorticoid receptors at postsynaptic membranes in the lateral amygdala
Johnson, L. R., Farb, C., Morrison, J. H., McEwen, B. S., & Ledoux, J. E. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.050 · Cited by 205 · see citing works
Richard, D., Lin, Q., & Timofeeva, E. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01428-0 · Cited by 204 · see citing works
Blank, T., Nijholt, I. M., Grammatopoulos, D. K., Randeva, H. S., Hillhouse, E. W., & Spiess, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-02-00700.2003 · Cited by 203 · see citing works
Self-citationGlucocorticoids, chronic stress, and obesity
Dallman, M. F., Pecoraro, N. C., La Fleur, S. E., Warne, J. P., Ginsberg, A. B., Akana, S. F., Laugero, K. C., Houshyar, H., Strack, A. M., Bhatnagar, S., et al. (2006) · Progress in Brain Research · doi:10.1016/s0079-6123(06)53004-3 · Cited by 198 · see citing works
Baraban, S. C., & Tallent, M. K. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.01.008 · Cited by 187 · see citing works
Role of CRF 1 and CRF 2 receptors in fear and anxiety
Takahashi, L. K. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00046-x · Cited by 186 · see citing works
The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response
Dedic, N., Chen, A., & Deussing, J. M. (2017) · Current Molecular Pharmacology · doi:10.2174/1874467210666170302104053 · Cited by 181 · see citing works
Synaptic physiology of central CRH system
Gallagher, J. P., Orozco-Cabal, L. F., Liu, J., & Shinnick‐Gallagher, P. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.075 · Cited by 177 · see citing works
The therapeutic potential of CRF1 antagonists for anxiety
Zorrilla, E., & Koob, G. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.7.799 · Cited by 173 · see citing works
Sculpting the hippocampus from within: stress, spines, and CRH
Maras, P. M., & Baram, T. Z. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.01.005 · Cited by 174 · see citing works
Bakshi, V. P., Smith-Roe, S., Newman, S. M., Grigoriadis, D. E., & Kalin, N. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02926.2002 · Cited by 171 · see citing works
Kolber, B. J., Roberts, M. S., Howell, M. P., Wozniak, D. F., Sands, M. S., & Muglia, L. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803216105 · Cited by 169 · see citing works
Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors
Overstreet, D. H. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.11.010 · Cited by 169 · see citing works
Gilligan, P. J., Robertson, D. W., & Zaczek, R. C. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990590f · Cited by 160 · see citing works
Martı́nez, V., Wang, L., Rivier, J., Vale, W., & Taché, Y. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.611 · Cited by 159 · see citing works
Wang, X., Chen, Y., Wolf, M., Wagner, K. V., Liebl, C., Scharf, S. H., Harbich, D., Mayer, B., Wurst, W., Holsboer, F., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.020 · Cited by 157 · see citing works
Forebrain CRF1Modulates Early-Life Stress-Programmed Cognitive Deficits
Wang, X., Rammes, G., Kraev, I., Wolf, M., Liebl, C., Scharf, S. H., Rice, C. J., Wurst, W., Holsboer, F., Deussing, J. M., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2259-11.2011 · Cited by 156 · see citing works
Role of Corticotropin-Releasing Factor (CRF) Receptors in the Anorexic Syndrome Induced by CRF
Pelleymounter, M. A., Joppa, M. A., Carmouché, M., Cullen, M. J., Brown, B. T., Murphy, B., Grigoriadis, D. E., Ling, N., & Foster, A. C. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39300-0 · Cited by 151 · see citing works
The role of CRH in behavioral responses to stress
Smagin, G. N., Heinrichs, S. C., & Dunn, A. J. (2001) · Peptides · doi:10.1016/s0196-9781(01)00384-9 · Cited by 148 · see citing works
Henry, B., Vale, W., & Markou, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1494-06.2006 · Cited by 147 · see citing works
Valdez, G. R., & Koob, G. F. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.09.020 · Cited by 147 · see citing works
Pelleymounter, M. A., Joppa, M. A., LING, N. C., & Foster, A. C. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.145 · Cited by 147 · see citing works
Jasnow, A. M., Schulkin, J. A., & Pfaff, D. W. (2005) · Hormones and Behavior · doi:10.1016/j.yhbeh.2005.06.005 · Cited by 146 · see citing works
Snyder, K., Wang, W., Han, R., McFadden, K., & Valentino, R. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.218 · Cited by 143 · see citing works
Valdez, G. R., Inoue, K., Koob, G. F., Rivier, J., Vale, W., & Zorrilla, E. P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02707-5 · Cited by 143 · see citing works
Valdez, G. R., Zorrilla, E. P., Rivier, J., Vale, W., & Koob, G. F. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02971-8 · Cited by 140 · see citing works
Causes and Consequences of Stress
Greenberg, N. L. (2002) · Integrative and Comparative Biology · doi:10.1093/icb/42.3.508 · Cited by 140 · see citing works
Corticotropin-releasing factor signaling and visceral response to stress
Stengel, A., & Taché, Y. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.009347 · Cited by 139 · see citing works
Cyclin-Dependent Kinase 5 Is Required for Associative Learning
Fischer, A., Sananbenesi, F., Schrick, C., Spiess, J., & Radulović, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03700.2002 · Cited by 137 · see citing works
Self-citationTronson, N. C., Schrick, C., Guzman, Y. F., Huh, K. H., Srivastava, D. P., Penzes, P., Guedea, A. L., Gao, C., & Radulovic, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5619-08.2009 · Cited by 136 · see citing works
Lu, A., Steiner, M. A., Whittle, N., Vogl, A. M., Walser, S. M., Ableitner, M., Refojo, D., Ekker, M., Rubenstein, J. L. R., Stalla, G. K., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.51 · Cited by 136 · see citing works
Pedersen, W. A., Wan, R., Zhang, P., & Mattson, M. P. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00404.2002 · Cited by 135 · see citing works
Liu, J., Yu, B., Neugebauer, V., Grigoriadis, D. E., Rivier, J., Vale, W., Shinnick‐Gallagher, P., & Gallagher, J. P. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5531-03.2004 · Cited by 134 · see citing works
Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety
Takahashi, L. K., Ho, S. P., Livanov, V., Graciani, N., & Arneric, S. P. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02405-2 · Cited by 132 · see citing works
Bruijnzeel, A. W., Prado, M., & Isaac, S. K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.010 · Cited by 132 · see citing works
Valdez, G. R., Sabino, V., & Koob, G. F. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000128222.29875.40 · Cited by 131 · see citing works
Lukkes, J. L., Forster, G. L., Renner, K. J., & Summers, C. H. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.09.024 · Cited by 126 · see citing works
Bruijnzeel, A. W., & Gold, M. S. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.01.007 · Cited by 125 · see citing works
Pernar, L. I. M., Curtis, A. L., Vale, W., Rivier, J., & Valentino, R. J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2885-03.2004 · Cited by 124 · see citing works
Corticotropin-releasing hormone and animal models of anxiety: gene–environment interactions
Bakshi, V. P., & Kalin, N. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01082-9 · Cited by 124 · see citing works
Risbrough, V. B., Hauger, R. L., Roberts, A. L., Vale, W., & Geyer, M. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5760-03.2004 · Cited by 123 · see citing works
Molecular biology of the CRH receptors— in the mood
Dautzenberg, F. M., Kilpatrick, G. J., Hauger, R. L., & Moreau, J. (2001) · Peptides · doi:10.1016/s0196-9781(01)00388-6 · Cited by 123 · see citing works
Aguilar‐Valles, A., Sánchez, E., de Gortari, P., Balderas, I., Ramı́rez-Amaya, V., Bermúdez‐Rattoni, F., & Joseph‐Bravo, P. (2005) · Neuroendocrinology · doi:10.1159/000093129 · Cited by 121 · see citing works
Skelton, K. H., Nemeroff, C. B., Knight, D. L., & Owens, M. J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-03-01240.2000 · Cited by 119 · see citing works
Amat, J., Tamblyn, J. P., Paul, E. D., Bland, S. T., Amat, P., Foster, A. C., Watkins, L. R., & Maier, S. F. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.052 · Cited by 119 · see citing works
Chen, Y., Kramár, E. A., Chen, L. Y., Babayan, A. H., Andres, A. L., Gall, C. M., Lynch, G., & Baram, T. Z. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.17 · Cited by 115 · see citing works
Roozendaal, B., Schelling, G., & McGaugh, J. L. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1336-08.2008 · Cited by 115 · see citing works
Tan, H., Zhong, P., & Yan, Z. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0143-04.2004 · Cited by 112 · see citing works
Sananbenesi, F. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1188 · Cited by 110 · see citing works
Pelleymounter, M. A., Joppa, M. A., Ling, N., & Foster, A. C. (2004) · Peptides · doi:10.1016/j.peptides.2004.01.008 · Cited by 110 · see citing works
Rees, S. L., Panesar, S., Steiner, M. S., & Fleming, A. S. (2004) · Hormones and Behavior · doi:10.1016/j.yhbeh.2004.03.010 · Cited by 109 · see citing works
Sink, K. S., Walker, D. L., Freeman, S. M., Flandreau, E. I., Ressler, K. J., & Davis, M. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.188 · Cited by 108 · see citing works
Hippocampal Mek/Erk signaling mediates extinction of contextual freezing behavior
Fischer, A., Radulović, M., Schrick, C., Sananbenesi, F., Godovac‐Zimmermann, J., & Radulović, J. (2006) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2006.08.003 · Cited by 107 · see citing works
Risbrough, V. B., Hauger, R. L., Pelleymounter, M. A., & Geyer, M. A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1535-6 · Cited by 107 · see citing works
The CRF system and social behavior: a review
Hostetler, C. M., & Ryabinin, A. E. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00092 · Cited by 105 · see citing works
Translating Across Circuits and Genetics Toward Progress in Fear- and Anxiety-Related Disorders
Ressler, K. J. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20010055 · Cited by 104 · see citing works
Kamprath, K., Plendl, W., Marsicano, G., Deussing, J. M., Wurst, W., Lutz, B., & Wotjak, C. T. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2008.00463.x · Cited by 104 · see citing works
Kehne, J. H., & Cain, C. K. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.011 · Cited by 104 · see citing works
Stress and the Neuroendocrinology of Anxiety Disorders
Pêgo, J. M., Sousa, J. C., Almeida, O., & Sousa, N. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_13 · Cited by 104 · see citing works
On the role of corticotropin-releasing hormone receptors in anxiety and depression
Reul, J. M. H. M., & Holsboer, F. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.1/jreul · Cited by 103 · see citing works
“also observed 30 min after a 60-min immobilization trial, which was prevented by intraseptal, but not intradorsohippocampal, administration of antisauvagine-30 before the stress procedure.(55) Thus, acutely CRHR2-mediated signaling in the iLS results in anxiogenesis.”
BackgroundStiedl, O., Birkenfeld, K., Palve, M., & Spiess, J. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00269-2 · Cited by 103 · see citing works
Self-citationCorticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas
Refojo, D., Echenique, C., Müller, M. B., Reul, J. M. H. M., Deussing, J. M., Wurst, W., Sillaber, I., Páez-Pereda, M., Holsboer, F., & ARZT, E. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502070102 · Cited by 103 · see citing works
Involvement of the 5-HT1AReceptors in Classical Fear Conditioning in C57BL/6J Mice
Stiedl, O., Misane, I., Spiess, J., & Ögren, S. O. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08515.2000 · Cited by 102 · see citing works
Self-citationLü, L., Liu, D., & Ceng, X. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00840-8 · Cited by 98 · see citing works
Corticotropin-releasing factor induces social preferences in male prairie voles
DeVries, A. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00073-7 · Cited by 97 · see citing works
N-Cadherin Regulates Cytoskeletally Associated IQGAP1/ERK Signaling and Memory Formation
Schrick, C., Fischer, A., Srivastava, D. P., Tronson, N. C., Penzes, P., & Radulović, J. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.034 · Cited by 97 · see citing works
- Authors
- Radulovic, J., Rühmann, A., Liepold, T., & Spiess, J.
- Affiliations
- Max Planck Institute of Experimental Medicine (DE)
- ORCID
- Liepold, Thomas
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1999-06-15
- Volume
- 19
- Issue
- 12
- Pages
- 5016-5025
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6782638
- OpenAlex
- W1633118497
- Cited by
- 402
- References
- 55
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 11 · 2020: 6 · 2019: 8 · 2018: 5 · 2017: 11 · 2016: 8 · 2015: 13 · 2014: 14 · 2013: 15 · 2012: 14
- FWCI
- 15.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Max-Planck-Gesellschaft
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- corticotropin-releasing factor, CRF1 receptor, CRF receptor 2, fear conditioning, memory consolidation, anxiety, dorsal hippocampus, astressin, antisauvagine-30, restraint stress, stress response, associative learning
- MeSH terms
- CRF Receptor, Type 1, Acoustic Stimulation, Animals, Anxiety, Behavior, Animal, Brain Chemistry, Conditioning, Psychological, Corticotropin-Releasing Hormone, Dose-Response Relationship, Drug, Fear, Hippocampus, Male, Mice, Inbred BALB C, Peptide Fragments, Septal Nuclei, Stress, Psychological, Receptors, Corticotropin-Releasing Hormone, Neuroprotective Agents, Maze Learning, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review